Shared by
beno
Fundamentals
Shares Outstanding: 3.45m
Cash: 14.86m
Current liabilities: 1.5m
Current ratio: 10
NWC (total current assets - total current liabilities): 13.68m
Monthly Burn rate (net cash used in operating activities / months): 569k
Estimated current cash: 13.721m
Accumulated deficit: 81.3m
Book value per share (Stock holder equity / Shares outstanding): 4.70
Baby Shelf Exemption price per share: 21.74
Technical Analysis
-Typical gap and crap pattern, action mostly in PM and at open
-Levels: 3.57, 3.7, 4.10, 4.30, 4.50
Catalysts / News / Painting the picture
CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver Disease
Only diluted 247,0130 shares since December 2018
2019 S-3 with $100m registered, no prospectus or ATM yet
Original Plan / Strategy
First Test long strategy off of 4.10 PM level
Review
Classic First Test scalp that was a success, didn't trade with large size due to low volume.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2019-11-21 09:10:33 | HEPA | buy | $4.070 | long |
| 2019-11-21 09:13:58 | HEPA | sell | $4.180 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!